Citigroup’s CRH Medical Corporation CRHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,700
Closed -$14K 7896
2018
Q4
$14K Buy
4,700
+2,800
+147% +$9.23K ﹤0.01% 7049
2018
Q3
$8K Buy
+1,900
New +$7K ﹤0.01% 7425
2017
Q4
Sell
-197
Closed -$1K 7706
2017
Q3
$1K Sell
197
-24
-11% -$74 ﹤0.01% 7191
2017
Q2
$1K Buy
+221
New +$1.43K ﹤0.01% 7258
2016
Q1
Sell
-28
Closed 7906
2015
Q4
$0 Buy
+28
New +$78 ﹤0.01% 7995

Other funds holding CRHM

Citigroup's CRHM Position: Q1 2019 in Review

Citigroup sold out of CRH Medical Corporation (CRHM) in Q1 2019, closing a stake of 4,700 shares — an estimated $14K sold.

Citigroup first reported a position in CRHM in Q4 2015 and held it in 5 quarters. The position peaked at $14K in Q4 2018. 39 funds tracked by Wall St. Rank hold CRHM as of Q1 2019.

  • Citigroup reported no remaining CRH Medical Corporation position as of Q1 2019 after selling out during the quarter.
  • Citigroup sold 4,700 CRH Medical Corporation shares in Q1 2019, an estimated $14K.
  • Citigroup first reported a position in CRH Medical Corporation in Q4 2015 and held it in 5 quarters.
  • Citigroup's CRH Medical Corporation position peaked at $14K in Q4 2018.
  • 39 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2019.

Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.